- Home
- CLGN vs FLGC Comparison
CLGN vs FLGC Comparison
Compare CLGN & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- FLGC
- Stock Information
- Founded
- CLGN 2004
- FLGC 2019
- Country
- CLGN Israel
- FLGC United States
- Employees
- CLGN N/A
- FLGC N/A
- Industry
- CLGN Industrial Specialties
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- FLGC Health Care
- Exchange
- CLGN Nasdaq
- FLGC Nasdaq
- Market Cap
- CLGN 19.1M
- FLGC 15.9M
- IPO Year
- CLGN N/A
- FLGC 2021
- Fundamental
- Price
- CLGN $2.63
- FLGC $24.10
- Analyst Decision
- CLGN Strong Buy
- FLGC Buy
- Analyst Count
- CLGN 2
- FLGC 2
- Target Price
- CLGN $11.50
- FLGC $156.00
- AVG Volume (30 Days)
- CLGN 45.8K
- FLGC 15.3K
- Earning Date
- CLGN 08-20-2025
- FLGC 08-01-2025
- Dividend Yield
- CLGN N/A
- FLGC N/A
- EPS Growth
- CLGN N/A
- FLGC N/A
- EPS
- CLGN N/A
- FLGC N/A
- Revenue
- CLGN $2,472,000.00
- FLGC $52,373,000.00
- Revenue This Year
- CLGN $1,999.42
- FLGC N/A
- Revenue Next Year
- CLGN $69.81
- FLGC N/A
- P/E Ratio
- CLGN N/A
- FLGC N/A
- Revenue Growth
- CLGN N/A
- FLGC N/A
- 52 Week Low
- CLGN $1.31
- FLGC $15.15
- 52 Week High
- CLGN $5.45
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- CLGN 60.49
- FLGC 46.44
- Support Level
- CLGN $2.59
- FLGC $17.60
- Resistance Level
- CLGN $3.23
- FLGC $24.85
- Average True Range (ATR)
- CLGN 0.29
- FLGC 2.96
- MACD
- CLGN 0.03
- FLGC -0.12
- Stochastic Oscillator
- CLGN 55.86
- FLGC 50.56
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.